ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy

Name: ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy
Published: 2019
License: Public Domain

Rakuten Medical, Inc. · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

egfr head-and-neck-cancer

head and neck cancer, rakuten medical, asp-1929, pit, photoimmunotherapy, hnc, hnscc, head and neck, egfr, cetuximab, erbitux, rm-1929

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 878583
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.